HPV vaccination of girls offers benefits to men but does not reduce risk of some cancers
the ONA take:
The association between human papillomavirus (HPV) and cervical cancer in women is well established.
Furthermore, vaccinating girls has had a positive impact on the incidence of cervical cancer in many countries in which the practice was adopted.
Men benefit indirectly from vaccinating girls in that their risk of contracting HPV is reduced; however, this does not protect men from cancers associated with the virus.
The HPV vaccine has been found effective in boys, but universal vaccination of boys is practiced in only a few countries (Australia, Austria, two Canadian provinces, and the United States).
Dutch researchers sought to estimate the benefit to men if boys were vaccinated against HPV, as well.
Their findings show that benefits from vaccinating boys would not be as significant as they are in girls. Therefore, the researchers suggest that programs for vaccinating girls should continue but including boys may be warranted.
Men benefit indirectly but not from cancer risk associated with the virus.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Mammograms (Fact Sheet)
- Shifts in Cancer Burden for People With HIV Projected
- Tissue Biobank Procurement Consent Should Include Discussion of Confidentiality Risks
- Health Care Expansion Tied to Increased Rates of Surgical Treatment of Thyroid Cancer
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|